Drug registration with generic name has to be approved.

The community pharmacy circles and the Korea pharmaceutical association (KPA) raised an issue about a regulatory possibility for the single drug registration with generic name to be granted while the pharmaceutical industries kept a solid position that the branded drug registration should be allowed and changeable from the drug described with a brand plus generic name if necessary afterward.

...